Merck & (MRK) Revenue — Quarter Ended Jun 30, 2024
Merck reported higher revenue for the quarter, with growth compared to both the prior quarter and the same quarter last year. The results reflect continued positive performance.
Key takeaway
Quarter ended Jun 30, 2024 · FY2024 Q2
Merck reported higher revenue for the quarter, with growth compared to both the prior quarter and the same quarter last year. The results reflect continued positive performance.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$16.1B
Revenue reported for this quarter.
Quarter-over-quarter
+2.1%
Change from the immediately preceding quarter.
Year-over-year
+7.2%
Change from the comparable year-ago quarter.
Trailing four quarters
$62.5B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Sep 30, 2023 | $16B | +6.7% |
| Dec 31, 2023 | $14.6B | +5.8% |
| Mar 31, 2024 | $15.8B | +8.9% |
| Jun 30, 2024 | $16.1B | +7.2% |
Revenue performance
Revenue increased sequentially and year over year, marking another period of expansion.
Quarterly comparison
Compared to the immediately preceding quarter, revenue was up, and it also rose from the same quarter one year earlier. This indicates sustained revenue momentum.
What to watch
Investors should keep an eye on whether Merck can maintain this revenue growth trajectory in upcoming quarters.